{
    "id": 2908,
    "fullName": "SETBP1 mutant",
    "impact": "unknown",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "SETPB1 mutant indicates an unspecified mutation in the SETBP1 gene.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "category",
    "gene": {
        "id": 26040,
        "geneSymbol": "SETBP1",
        "terms": [
            "SETBP1",
            "MRD29",
            "SEB"
        ]
    },
    "variant": "mutant",
    "createDate": "01/07/2015",
    "updateDate": "09/06/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 1596,
            "approvalStatus": "Preclinical",
            "evidenceType": "Emerging",
            "efficacyEvidence": "In a preclinical study, SETPB1 missense mutations conferred a predicted gain-of-function, resulting in transformation of murine myeloid progenitors and increased Pp2ac phosphorylation compared to wild-type SETBP1 in culture, suggesting that Setbp1 may serve as a potential therapeutic target (PMID: 23832012).",
            "molecularProfile": {
                "id": 2731,
                "profileName": "SETBP1 mutant"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 4972,
                "name": "myelodysplastic/myeloproliferative neoplasm",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 1599,
                    "pubMedId": 23832012,
                    "title": "Somatic SETBP1 mutations in myeloid malignancies.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23832012"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 13559,
            "approvalStatus": "Clinical Study",
            "evidenceType": "Prognostic",
            "efficacyEvidence": "In clinical analyses, mutations in SETBP1 were associated with poor prognosis in patients with myelodysplastic syndrome (PMID: 28447248, PMID: 28158286, PMID: 24127063, PMID: 23889083, PMID: 23832012).",
            "molecularProfile": {
                "id": 2731,
                "profileName": "SETBP1 mutant"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 50908,
                "name": "myelodysplastic syndrome",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 1599,
                    "pubMedId": 23832012,
                    "title": "Somatic SETBP1 mutations in myeloid malignancies.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23832012"
                },
                {
                    "id": 11187,
                    "pubMedId": 28447248,
                    "title": "Somatic SETBP1 mutations in myeloid neoplasms.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28447248"
                },
                {
                    "id": 11189,
                    "pubMedId": 28158286,
                    "title": "Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28158286"
                },
                {
                    "id": 11190,
                    "pubMedId": 24127063,
                    "title": "Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24127063"
                },
                {
                    "id": 11191,
                    "pubMedId": 23889083,
                    "title": "Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progression.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23889083"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        },
        {
            "id": 13561,
            "approvalStatus": "Clinical Study",
            "evidenceType": "Prognostic",
            "efficacyEvidence": "In clinical analyses, mutations in SETBP1 were associated with poor prognosis in patients with chronic myelomonocytic leukemia (PMID: 29225884, PMID: 28158286, PMID: 28209919, PMID: 23558523, PMID: 23832012).",
            "molecularProfile": {
                "id": 2731,
                "profileName": "SETBP1 mutant"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 80188,
                "name": "chronic myelomonocytic leukemia",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 1599,
                    "pubMedId": 23832012,
                    "title": "Somatic SETBP1 mutations in myeloid malignancies.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23832012"
                },
                {
                    "id": 11189,
                    "pubMedId": 28158286,
                    "title": "Prognostic significance of SETBP1 mutations in myelodysplastic syndromes, chronic myelomonocytic leukemia, and chronic neutrophilic leukemia: A meta-analysis.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28158286"
                },
                {
                    "id": 11192,
                    "pubMedId": 23558523,
                    "title": "SETBP1 mutations in 415 patients with primary myelofibrosis or chronic myelomonocytic leukemia: independent prognostic impact in CMML.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23558523"
                },
                {
                    "id": 11193,
                    "pubMedId": 28209919,
                    "title": "Clinical significance of CSF3R, SRSF2 and SETBP1 mutations in chronic neutrophilic leukemia and chronic myelomonocytic leukemia.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28209919"
                },
                {
                    "id": 11194,
                    "pubMedId": 29225884,
                    "title": "SETBP1 mutations as a biomarker for myelodysplasia /myeloproliferative neoplasm overlap syndrome.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29225884"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 2731,
            "profileName": "SETBP1 mutant",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}